Essay questions Flashcards
Experiment to show that Enac has a function in controlling height of ASL
- Add excess fluid
- Mimic in vivo conditions of breathing- moving back and forwards
- look at rate of decrease of height due to change in trans epithelial potential due to changes in Cl secretion and Na reabsorption
- Butamide and Amiloride inhibition over time
- 0 hr lots of Amiloride inhibition but decreases to 30% after 48hours
- Ohr less butamide is 55% inhibition at 48hours
shows more Cl secretion needed to maintain ASL than Na reabsorption but both help maintain the layer
RSV experiments
- Look at the effect of RSV on amiloride sensitive ssc
- Add amiloride
- then add either control or RSV for an hour
- then re add amiloride and see if there is a change in deflection
RSV= decrease deflection of amiloride as less enac is functioning - Look at which pathways of ENAC RSV interacts with
- PKC (BIM inhibitor), Glycoprotein (NA inhibitor), Glycolipid (PMCD)
- If you add inhibitor then there will be no effect of amiloride as the enac is already blocked- PKC AND GLYCOLIPID
Experiments for Influenza
- prove that M2 causes long term influenza
- Overexpressed Enac and it inhibited Enac
- decrease open probability of Enac- less deflections when M2 is overexpressed
- caused endocytosis- western blott showed less alpha subunit and Beta subunit present when M2 overexpressed
- showed there was less enac due to increased endocytosis- used liddles where endocytosis cant occur and showed that M2 couldn’t endocytose when liddles occurs - look at mechanism of how M2 acts on enac
- immunostaining- RFP-M2 Or RFP alone
- ROS= green
Results- in areas overexpressed with M2 (red) there is also green staining so ROS has accumulated
Part 2- prove ros is involved
- inhibited ROS with GSK- antioxidant that scavenges ros
- also inhibited PKC by Inhib and GO6967 which blocks
- Inhibiting PKC or M2 expressed more Enac
How is Cl secreted?
- Experiment to show DF created- look at rectal shark model
- oubain- Na/K ATPase inhibitor- reduces NKCC and therefore Cl secretion as cant set up the df. Maintains low IC Na
- Barium- blocks K- hyperpolarises the cell, Vte -1 to 0- DF for Cl secretion
- Furoesmide- NKCC inhibitor- stops Cl influx into cell for CFTR to secrete - Above electrochemical gradient
- no active process then ic would be the same as EC
- we got 17mM but actually 70mM as active process causing accumulation of cl- this is Na/K ATPase
- above electrochemical gradient means Cl channels just have open for CL secretion
Experiment to look at mechanism of CFTR
Isolated rat CFTR
looked at the water content- which is dependent on Cl secretion by CF- Secrete Cl and water follow
PGE2- Increases cAMP- increases CFTR- increases Cl secretion
Ach- increases IC Ca- activates apical and basolateral Cl
- Open CFTR= Cl secretion
- Open K channel= hyperpolarises
Experiment to look at the activation of CF and Non CF
Ussing chamber experiment
Look at effect of cAMP secretion
- indomethacin- inhibits PG- decrease cAMP
- Imbx- inhibits phosphodiesterase- increase cAMP
- CCB- increase Ach- increase cAMP
- forskin- increase AC- increase CAMP
block amiloride to stop contamination
- stimulate with ccb- increase Cl secretion- increase neg shift Vte
- CCB +indomethacin- block cl secretion- DF there but channel is closed
- CCB+ indomethacin+ imbx- bypass and increase Cl secretion
*CF patient no effect= CFTR channel is not functional
What experiment would you include in VX770 and G551D
- Drug screening
- Rat thyroid- add VX770 +FSK +G551D
- Expression system- Vx770 + PKA and ATP
- Look at Vx770 in native cell- Human bronchial cell- amiloride sensitive ssc in double mutant when adding 770 and FSK
- Effect of 770 on ASL layer- add fluid and VIP (increase CAMP) and see how 770 increases ASL
- Look at how 770 effects CBF
- clinical trial in humans- G551D and 770- FEV1%- improvement, pulmonary exacerbation and sweat cl
- G551D and Vx770 in Human nasal cells, quirt in Cl free solution and isotopreneral to secrete B agonists and increase CAMP- look at Cl secretion
Experiment to look at F508
- drug screening- compounds that drive immature to mature
- F508 and VX809 ratio of mature to immature
- pulse chase experiment HEK and CFTR - amount of mature and immature depends on the length of time cells are exposed to vx809
4.
How do you screen for G551D and F508
G551D- Increase in fluorescence vm assay when increase membrane potential- which means gating worked
- tested 228,000 chemicals
- look at nerst= Cl
- found VX770
f805- immunoblot assay to see which chemical drive CFTR glycosylation and become mature
- see 2 bands
- glycosylated is higher MW band
Look at the effect of VX770
Rat thyroid cells
stimulated G551D and control with FSK (increase cAMP)
G551D + FSK- small increase in isc
GSS1D+ FSK + 770- increases currents of cl secretion- 12-15% of wt- only needs to be that to get normal function
Prove it was CFTR that increase Cl secretion by inhibiting
Expression system 770
In vivo
- look at the effect of PKA and ATP looked at deflections
G551D- few deflections even in presence of PKA and ATP
G551D + 770- channels open, potentiator- increase Cl secretion
Effect of 770 on human cells
Human bronchiole epithelial cells Block amiloride= contamination - severe CF- contain 2 mutations in G551D/F508 - add FSK to stimulate WT- 56uA FSK induced ssc G551D/f508 +fsk= 2.9uA mutant + FSK + 770= 27uA= 48% of wt enough to alleviate the symptoms of CF
Looking at the effect of 770 on ASL
Amiloride to block enac
added excess fluid to the layer
Used VIP- increase cAMP
WT- add excess, stimulate with VIP and the layer decreases then plateaus
G551D +VIP- massive decrease in liquid layer
+ 770- increase ASL- in-between wt and mutant
Looked at the effect on CBF
decrease ASL= decrease CBF
- G551D + VIP- decreased CBF- struggle to beat- restored when liquid is added on top
+779- restores normal layer
Clinical trial for 770
83 patients with CF- mutations in atleast 1 CFTR random double blind and placebo - Looked at FEV1% - Pos= improvement neg= worsening
Results
- add VX770 to G551D
FEV1% Improves drastically over 2 weeks and whole time whereas placebo worsens
- Pulmmonary excabertion- Ivacaftor- 67% haven’t, placebo- 40% haven’t
- Sweat cl- drops below threshold
Part 2 of Trial
Inserted Cl free solution containing Isoprenterol (increase cAMP) into nasal passage- initiates Cl secretion
CFTR working then there is a negative shift in potential as more Cl secretion occurring
VX770- 75 and 150mg- increased Cl secretion
direct experiment